The FDA has approved the first gene therapy for the treatment of Duchenne muscular dystrophy (DMD) in children 4-5 years of ...
Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a ...
The Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial virus (RSV) vaccine for use ...
Pfizer (PFE) stock gains as lung cancer therapy, Lorbrena, shows promising results in reducing disease progression or death ...
The European Medicines Agency has recommended the use of Pfizer's gene therapy for a rare bleeding disorder called hemophilia ...
An ongoing study showed that 60% of lung cancer patients who took a drug called Lorbrena remained alive and disease-free ...
I just feel very convinced that I had to vote no,” said one member of the committee, which was unconvinced by Lykos Therapeutics’ data on MDMA-assisted treatment for post-traumatic stress disorder.
Current health news includes Pfizer's lung cancer drug Lorbrena potentially hitting $1 billion in sales by 2030, U.S.
This health news summary spotlights major developments in cancer treatments, regulatory actions on biotechnology, and the ...
Explore the latest breakthroughs in cervical cancer treatment, including Pfizer's Tivdak, recently approved by U.S.
DelveInsight's analysis estimates that the postherpetic neuralgia market is expected to show positive growth, mainly ...
The global cell and gene therapy market is experiencing significant growth, driven by technological advancements, increasing ...